Erschienen in:
01.09.2009 | Commentary
Devastating yet treatable complication of tuberculous meningitis: the resistant TB abscess
verfasst von:
A. K. Mahapatra
Erschienen in:
Child's Nervous System
|
Ausgabe 9/2009
Einloggen, um Zugang zu erhalten
Excerpt
Tuberculous meningitis (TBM) is still very common in India and is also seen in pediatric population according to ICMR study 2004, 2005 [
1]. In the last decade, a large number of studies were available dealing with drug resistant TB [
2,
3]. More than 30% of all new TB cases occurring in the world are reported in India, and approximately 500,000 people die in India due to tuberculosis, every year. More alarmingly, 25–30% of tuberculosis reported in India [
1,
4] is termed as multidrug resistant (MDR), and among them, 2–3% are leveled as extreme drug resistant. We also observe many patients resistant to first-line TB drug; then, the second-line drugs are started after 2–3 months of antitubercular treatment (ATT) of first-line drug. …